.svg){kind=small}
Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Aliviar has shown consistent performance in the Tincture & Sublingual category in Colorado, maintaining its 7th place ranking in both September and October 2024. This stability in ranking suggests a steady demand and potentially loyal customer base for their products in this category. The absence of rankings for November and December 2024 indicates that Aliviar may have fallen out of the top 30 brands during these months, which could be a sign of increased competition or a shift in consumer preferences. Despite this, the sales figures from September to October show an upward trend, with a notable increase from $11,663 to $13,141, reflecting a positive reception in the earlier months of the period.
It is crucial to monitor how Aliviar navigates the competitive landscape in Colorado moving forward, especially given the potential challenges highlighted by their absence in the top 30 rankings towards the end of 2024. This could present an opportunity for the brand to reassess its strategies and explore ways to regain its standing. Observing how Aliviar adapts to these market dynamics and whether they can leverage their previous momentum to re-enter the rankings will be an interesting development. The insights gathered from this period could inform future strategies not only in Colorado but potentially in other markets as well.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Colorado, Aliviar has shown a notable fluctuation in its market position. While Aliviar maintained a consistent rank of 7th place in September and October 2024, it dropped out of the top 20 by November and December, indicating a significant decline in its competitive standing. This contrasts with Stratos, which held steady at 4th place in September and October before slipping to 5th in the following months, and SUM Microdose, which improved its rank from 8th to 6th in November before slightly declining to 7th in December. The sales data suggests that while Aliviar experienced a temporary increase in October, its inability to maintain visibility in the top 20 could be attributed to stronger performances by competitors, especially as SUM Microdose showed a consistent upward trend in sales during the same period. This dynamic highlights the importance for Aliviar to reassess its market strategies to regain its competitive edge in the Colorado market.
Notable Products
In December 2024, Aliviar's top-performing product was the CBD/THC 20:1 Calm Tincture, maintaining its number one rank consistently from September through December, despite a drop in sales to 151 units. The CBD/THC/CBN 5:1:1 Sleep Tincture also held steady in second place throughout the same period. The CBD/THC 2:1 Unscented Cream climbed back to third place in December after slipping to fifth in November, indicating a resurgence in popularity. The CBD/THC 2:1 Lavender Cream reappeared in the rankings at fourth place, having been absent in November, which suggests a renewed interest. Notably, the CBD/THC 2:1 Scented Cream, which was ranked third in November, did not appear in the December rankings, indicating a significant decline in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
